Trademark: 86119908
Status Date
Monday, September 18, 2017
Filing Date
Friday, November 15, 2013
Published for Opposition
Tuesday, June 23, 2015
Abandoned Date
Monday, September 18, 2017
1 Antibodies, enzymes and nucleic acids for scientific and research use; Antibodies for the detection of signaling molecules, post-translational modifications on signaling molecules, non-radioactive kinase and other enzyme assays, kinase and other enzyme inhibitors designed for use in biotechnological and biomedical research; biochemical reagents commonly known as probes, for detecting and analyzing molecules in protein or nucleotide arrays; biochemicals, namely, monoclonal antibodies for in vitro scientific or research use; diagnostic kits consisting of reagents for scientific or research use; diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents to monitor toxicity of drugs; diagnostic preparations for scientific or research use; diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; laboratory chemicals, namely, an antibody reagent used for the detection of antigens in cell and tissue analysis for in vitro diagnostic use; reagents for use in the development of therapeutic substances; reagents for research purposes; reagents for use in scientific apparatus for chemical and biological analysis
5 Diagnostic kits consisting of reagents for therapeutic use; diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; diagnostic reagents and contrast media for medical use; diagnostic reagents for therapeutic use; diagnostic reagents for medicinal use; drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids; medical diagnostic reagents
42 Biological research in the field of proteomics and cellular signal transduction; consulting services in the fields of biotechnology, pharmaceutical research and developments, laboratory testing, diagnostics and pharmacogenetics; custom design and development of chemical reagents and biochemical assays for others; diagnostic services in the field of proteomics and cellular signal transduction; providing reagent sample testing and diagnostic services for others in the fields of science and scientific research
"BIOSCIENCES"
CELL SIGNALING TECHNOLOGY BIOSCIENCES
Sep 18, 2017
Abandonment Notice Mailed - No Use Statement Filed
Sep 18, 2017
Abandonment - No Use Statement Filed
Feb 21, 2017
Notice Of Approval Of Extension Request E-Mailed
Feb 17, 2017
Extension 3 Granted
Feb 17, 2017
Extension 3 Filed
Feb 17, 2017
Teas Extension Received
Sep 13, 2016
Notice Of Approval Of Extension Request E-Mailed
Sep 12, 2016
Extension 2 Granted
Aug 18, 2016
Extension 2 Filed
Sep 9, 2016
Case Assigned To Intent To Use Paralegal
Aug 18, 2016
Teas Extension Received
Jan 27, 2016
Notice Of Approval Of Extension Request E-Mailed
Jan 25, 2016
Extension 1 Granted
Jan 25, 2016
Extension 1 Filed
Jan 25, 2016
Teas Extension Received
Aug 18, 2015
Noa E-Mailed - Sou Required From Applicant
Jun 23, 2015
Official Gazette Publication Confirmation E-Mailed
Jun 23, 2015
Published For Opposition
Jun 3, 2015
Notification Of Notice Of Publication E-Mailed
May 16, 2015
Law Office Publication Review Completed
May 13, 2015
Approved For Pub - Principal Register
May 7, 2015
Teas/Email Correspondence Entered
May 7, 2015
Correspondence Received In Law Office
May 1, 2015
Teas Request For Reconsideration Received
Dec 1, 2014
Notification Of Final Refusal Emailed
Dec 1, 2014
Final Refusal E-Mailed
Dec 1, 2014
Final Refusal Written
Nov 5, 2014
Teas/Email Correspondence Entered
Nov 5, 2014
Correspondence Received In Law Office
Nov 5, 2014
Teas Response To Office Action Received
May 5, 2014
Notification Of Non-Final Action E-Mailed
May 5, 2014
Non-Final Action E-Mailed
May 5, 2014
Non-Final Action Written
Apr 1, 2014
Previous Allowance Count Withdrawn
Apr 1, 2014
Approved For Pub - Principal Register
Mar 11, 2014
Assigned To Lie
Mar 11, 2014
Examiner's Amendment Entered
Mar 10, 2014
Notification Of Examiners Amendment E-Mailed
Mar 10, 2014
Examiners Amendment E-Mailed
Mar 10, 2014
Examiners Amendment -Written
Mar 3, 2014
Assigned To Examiner
Dec 3, 2013
Notice Of Pseudo Mark E-Mailed
Nov 30, 2013
New Application Office Supplied Data Entered In Tram
Nov 19, 2013
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
